发布求助
文献互助 智能选刊 最新文献

Hematology-Oncology Clinics of North America最新文献

筛选
英文 中文
Emergence of Circulating Tumor DNA as a Precision Biomarker in Lung Cancer Radiation Oncology and Beyond.
IF 2.5 3区 医学
Hematology-Oncology Clinics of North America Pub Date : 2024-12-27 DOI: 10.1016/j.hoc.2024.11.002
Ayesha Hashmi, Lilli J Greiner, Pradeep S Chauhan, Jeffrey J Szymanski, Sean Park, Kenneth Olivier, Dawn Owen, Aadel A Chaudhuri
{"title":"Emergence of Circulating Tumor DNA as a Precision Biomarker in Lung Cancer Radiation Oncology and Beyond.","authors":"Ayesha Hashmi, Lilli J Greiner, Pradeep S Chauhan, Jeffrey J Szymanski, Sean Park, Kenneth Olivier, Dawn Owen, Aadel A Chaudhuri","doi":"10.1016/j.hoc.2024.11.002","DOIUrl":"https://doi.org/10.1016/j.hoc.2024.11.002","url":null,"abstract":"<p><p>Circulating tumor DNA (ctDNA) is emerging as a transformative biomarker in the management of non-small cell lung cancer (NSCLC). This review focuses on its role in detecting minimal residual disease (MRD), predicting treatment response, and guiding therapeutic decision-making in radiation oncology and immunotherapy. Key studies demonstrate ctDNA's prognostic value, particularly in identifying relapse risk and refining patient stratification for curative-intent and consolidative treatments. Future research is essential to standardize ctDNA assays, optimize integration into clinical workflows, and expand its clinical utility. This biomarker holds substantial promise by enabling non-invasive, real-time monitoring and improving outcomes for patients with NSCLC and beyond.</p>","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142900453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gene Signatures and Oncology Treatment Implications.
IF 2.5 3区 医学
Hematology-Oncology Clinics of North America Pub Date : 2024-12-17 DOI: 10.1016/j.hoc.2024.11.003
Jessica Scarborough, Davis Weaver, Jacob Scott
{"title":"Gene Signatures and Oncology Treatment Implications.","authors":"Jessica Scarborough, Davis Weaver, Jacob Scott","doi":"10.1016/j.hoc.2024.11.003","DOIUrl":"https://doi.org/10.1016/j.hoc.2024.11.003","url":null,"abstract":"<p><p>Gene expression signatures (GES) are a powerful tool in oncology used for classification, prognostication, and therapeutic response prediction of malignancies. In this article, we review the disease site guidelines by the National Comprehensive Cancer Network that use GES for treatment planning and clinical use. We identified 4 cancer types for which treatment decisions are frequently influenced by GES. Future developments in the field of GES are likely to include expanded data sources to personalize radiation therapy dosing and predict response to immunotherapy. Ongoing challenges in GES may be addressed to ensure that all patients with cancer benefit from precision oncology.</p>","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heavy Ion Particle Therapy in Modern Day Radiation Oncology.
IF 2.5 3区 医学
Hematology-Oncology Clinics of North America Pub Date : 2024-12-17 DOI: 10.1016/j.hoc.2024.11.007
Xiaoying Liang, Homan Mohammadi, Kathryn C Moreno, Chris J Beltran, Adam L Holtzman
{"title":"Heavy Ion Particle Therapy in Modern Day Radiation Oncology.","authors":"Xiaoying Liang, Homan Mohammadi, Kathryn C Moreno, Chris J Beltran, Adam L Holtzman","doi":"10.1016/j.hoc.2024.11.007","DOIUrl":"https://doi.org/10.1016/j.hoc.2024.11.007","url":null,"abstract":"<p><p>Heavy ion radiotherapy is an emerging technology for treating radioresistant solid tumors. Unlike current low-linear energy transfer techniques, heavy ion radiotherapy, such as carbon ion radiotherapy, enhances the biologic effects related to cancer therapy. Prospective clinical evidence has demonstrated feasibility and efficacy in several disease sites, including head and neck, thoracic, central nervous system, gastrointestinal, pelvic tumors, and sarcomas. Although presently unavailable in the Americas, Mayo Clinic is constructing a heavy ion facility in the United States that is planned for clinical operation in 2028.</p>","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-Reported Outcomes in Radiation Oncology.
IF 2.5 3区 医学
Hematology-Oncology Clinics of North America Pub Date : 2024-12-17 DOI: 10.1016/j.hoc.2024.11.005
Erin McCammack, Sara Alcorn
{"title":"Patient-Reported Outcomes in Radiation Oncology.","authors":"Erin McCammack, Sara Alcorn","doi":"10.1016/j.hoc.2024.11.005","DOIUrl":"https://doi.org/10.1016/j.hoc.2024.11.005","url":null,"abstract":"<p><p>Patient-reported outcomes (PROs) assessments arguably provide the most accurate description of the patient experience, as they are directly derived from the patient without the filter of a provider. Utilizing instruments to assess PROs in radiation oncology enables a provider to measure pretreatment, on-treatment, and posttreatment symptoms. In the clinic, PROs are supplemental to physician-derived ratings that help create a complete clinical picture of a patient at a given time point to inform shared decision-making. A compilation of PROs that arise within trials, specific for given treatment regimes, will be invaluable for patients faced with choosing between options.</p>","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142857079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic Liver Tumors: The Path to Disease-Free Survival 转移性肝肿瘤：无病生存之路
IF 2.5 3区 医学
Hematology-Oncology Clinics of North America Pub Date : 2024-11-05 DOI: 10.1016/j.hoc.2024.09.002
Michael D’Angelica MD, FACS
{"title":"Metastatic Liver Tumors: The Path to Disease-Free Survival","authors":"Michael D’Angelica MD, FACS","doi":"10.1016/j.hoc.2024.09.002","DOIUrl":"10.1016/j.hoc.2024.09.002","url":null,"abstract":"","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":"39 1","pages":"Pages xiii-xiv"},"PeriodicalIF":2.5,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Metastatic Liver Tumors 转移性肝肿瘤的管理
IF 2.5 3区 医学
Hematology-Oncology Clinics of North America Pub Date : 2024-11-05 DOI: 10.1016/S0889-8588(24)00132-1
Michael D’Angelica (Editor)
{"title":"Management of Metastatic Liver Tumors","authors":"Michael D’Angelica (Editor)","doi":"10.1016/S0889-8588(24)00132-1","DOIUrl":"10.1016/S0889-8588(24)00132-1","url":null,"abstract":"","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":"39 1","pages":"Page i"},"PeriodicalIF":2.5,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver 肝弥漫转移癌的肝灌注治疗
IF 2.5 3区 医学
Hematology-Oncology Clinics of North America Pub Date : 2024-11-05 DOI: 10.1016/j.hoc.2024.08.007
H. Richard Alexander Jr. MD , Virginia Devi-Chou BA, MA
{"title":"Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver","authors":"H. Richard Alexander Jr. MD ,&nbsp;Virginia Devi-Chou BA, MA","doi":"10.1016/j.hoc.2024.08.007","DOIUrl":"10.1016/j.hoc.2024.08.007","url":null,"abstract":"","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":"39 1","pages":"Pages 177-190"},"PeriodicalIF":2.5,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Management of Genitourinary Cancer Liver Metastases 泌尿生殖系统癌症肝转移的手术治疗
IF 2.5 3区 医学
Hematology-Oncology Clinics of North America Pub Date : 2024-11-05 DOI: 10.1016/j.hoc.2024.08.003
Guillaume Martel MD, MSc, FRCSC, FACS , Kimberly A. Bertens MD, MPH, FRCSC, FACS , Christina Canil MD, FRCPC
{"title":"Surgical Management of Genitourinary Cancer Liver Metastases","authors":"Guillaume Martel MD, MSc, FRCSC, FACS ,&nbsp;Kimberly A. Bertens MD, MPH, FRCSC, FACS ,&nbsp;Christina Canil MD, FRCPC","doi":"10.1016/j.hoc.2024.08.003","DOIUrl":"10.1016/j.hoc.2024.08.003","url":null,"abstract":"","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":"39 1","pages":"Pages 89-102"},"PeriodicalIF":2.5,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contributors 贡献者
IF 2.5 3区 医学
Hematology-Oncology Clinics of North America Pub Date : 2024-11-05 DOI: 10.1016/S0889-8588(24)00134-5
{"title":"Contributors","authors":"","doi":"10.1016/S0889-8588(24)00134-5","DOIUrl":"10.1016/S0889-8588(24)00134-5","url":null,"abstract":"","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":"39 1","pages":"Pages iii-vi"},"PeriodicalIF":2.5,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Management of Colorectal Cancer Liver Metastases 结直肠癌肝转移的手术治疗
IF 2.5 3区 医学
Hematology-Oncology Clinics of North America Pub Date : 2024-11-05 DOI: 10.1016/j.hoc.2024.08.011
Chandrasekhar Padmanabhan MD , Daniel P. Nussbaum MD , Michael D’Angelica MD
{"title":"Surgical Management of Colorectal Cancer Liver Metastases","authors":"Chandrasekhar Padmanabhan MD ,&nbsp;Daniel P. Nussbaum MD ,&nbsp;Michael D’Angelica MD","doi":"10.1016/j.hoc.2024.08.011","DOIUrl":"10.1016/j.hoc.2024.08.011","url":null,"abstract":"","PeriodicalId":55060,"journal":{"name":"Hematology-Oncology Clinics of North America","volume":"39 1","pages":"Pages 1-24"},"PeriodicalIF":2.5,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信